GO ID | Source | Type | Description |
GO:0072562 |
IEA:Ensembl | C | blood microparticle |
GO:0042627 |
IEA:UniProtKB-KW | C | chylomicron |
GO:0070062 |
IEA:Ensembl | C | extracellular vesicular exosome |
GO:0034364 |
IEA:UniProtKB-KW | C | high-density lipoprotein particle |
GO:0034363 |
IEA:Ensembl | C | intermediate-density lipoprotein particle |
GO:0005634 |
IEA:Ensembl | C | nucleus |
GO:0034361 |
IEA:UniProtKB-KW | C | very-low-density lipoprotein particle |
GO:0016209 |
IEA:Ensembl | F | antioxidant activity |
GO:0001540 |
IEA:Ensembl | F | beta-amyloid binding |
GO:0017127 |
IEA:Ensembl | F | cholesterol transporter activity |
GO:0008201 |
IEA:UniProtKB-KW | F | heparin binding |
GO:0008289 |
IEA:Ensembl | F | lipid binding |
GO:0071813 |
IEA:Ensembl | F | lipoprotein particle binding |
GO:0046911 |
IEA:Ensembl | F | metal chelating activity |
GO:0097113 |
IEA:Ensembl | P | alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering |
GO:0048844 |
IEA:Ensembl | P | artery morphogenesis |
GO:0006874 |
IEA:Ensembl | P | cellular calcium ion homeostasis |
GO:0019934 |
IEA:Ensembl | P | cGMP-mediated signaling |
GO:0006707 |
IEA:Ensembl | P | cholesterol catabolic process |
GO:0033344 |
IEA:Ensembl | P | cholesterol efflux |
GO:0042632 |
IEA:Ensembl | P | cholesterol homeostasis |
GO:0034382 |
IEA:Ensembl | P | chylomicron remnant clearance |
GO:0055089 |
IEA:Ensembl | P | fatty acid homeostasis |
GO:0007186 |
IEA:Ensembl | P | G-protein coupled receptor signaling pathway |
GO:0034380 |
IEA:Ensembl | P | high-density lipoprotein particle assembly |
GO:0034384 |
IEA:Ensembl | P | high-density lipoprotein particle clearance |
GO:0034375 |
IEA:Ensembl | P | high-density lipoprotein particle remodeling |
GO:0042158 |
IEA:Ensembl | P | lipoprotein biosynthetic process |
GO:0042159 |
IEA:Ensembl | P | lipoprotein catabolic process |
GO:0015909 |
IEA:Ensembl | P | long-chain fatty acid transport |
GO:0034374 |
IEA:Ensembl | P | low-density lipoprotein particle remodeling |
GO:0051651 |
IEA:Ensembl | P | maintenance of location in cell |
GO:1902430 |
IEA:Ensembl | P | negative regulation of beta-amyloid formation |
GO:0043537 |
IEA:Ensembl | P | negative regulation of blood vessel endothelial cell migration |
GO:0045541 |
IEA:Ensembl | P | negative regulation of cholesterol biosynthetic process |
GO:0090370 |
IEA:Ensembl | P | negative regulation of cholesterol efflux |
GO:0061000 |
IEA:Ensembl | P | negative regulation of dendritic spine development |
GO:1902951 |
IEA:Ensembl | P | negative regulation of dendritic spine maintenance |
GO:0001937 |
IEA:Ensembl | P | negative regulation of endothelial cell proliferation |
GO:0050728 |
IEA:Ensembl | P | negative regulation of inflammatory response |
GO:1903001 |
IEA:Ensembl | P | negative regulation of lipid transport across blood brain barrier |
GO:0043407 |
IEA:Ensembl | P | negative regulation of MAP kinase activity |
GO:1901215 |
IEA:Ensembl | P | negative regulation of neuron death |
GO:1902999 |
IEA:Ensembl | P | negative regulation of phospholipid efflux |
GO:0010544 |
IEA:Ensembl | P | negative regulation of platelet activation |
GO:1901627 |
IEA:Ensembl | P | negative regulation of postsynaptic membrane organization |
GO:1901630 |
IEA:Ensembl | P | negative regulation of presynaptic membrane organization |
GO:0007263 |
IEA:Ensembl | P | nitric oxide mediated signal transduction |
GO:0097114 |
IEA:Ensembl | P | N-methyl-D-aspartate receptor clustering |
GO:0033700 |
IEA:Ensembl | P | phospholipid efflux |
GO:1902004 |
IEA:Ensembl | P | positive regulation of beta-amyloid formation |
GO:0030828 |
IEA:Ensembl | P | positive regulation of cGMP biosynthetic process |
GO:0010875 |
IEA:Ensembl | P | positive regulation of cholesterol efflux |
GO:0060999 |
IEA:Ensembl | P | positive regulation of dendritic spine development |
GO:1902952 |
IEA:Ensembl | P | positive regulation of dendritic spine maintenance |
GO:0046889 |
IEA:Ensembl | P | positive regulation of lipid biosynthetic process |
GO:1903002 |
IEA:Ensembl | P | positive regulation of lipid transport across blood brain barrier |
GO:0032805 |
IEA:Ensembl | P | positive regulation of low-density lipoprotein particle receptor catabolic process |
GO:0051044 |
IEA:Ensembl | P | positive regulation of membrane protein ectodomain proteolysis |
GO:1902998 |
IEA:Ensembl | P | positive regulation of neurofibrillary tangle assembly |
GO:1901216 |
IEA:Ensembl | P | positive regulation of neuron death |
GO:0051000 |
IEA:Ensembl | P | positive regulation of nitric-oxide synthase activity |
GO:1902995 |
IEA:Ensembl | P | positive regulation of phospholipid efflux |
GO:1901628 |
IEA:Ensembl | P | positive regulation of postsynaptic membrane organization |
GO:1901631 |
IEA:Ensembl | P | positive regulation of presynaptic membrane organization |
GO:0017038 |
IEA:Ensembl | P | protein import |
GO:0006898 |
IEA:Ensembl | P | receptor-mediated endocytosis |
GO:1900221 |
IEA:Ensembl | P | regulation of beta-amyloid clearance |
GO:0032489 |
IEA:Ensembl | P | regulation of Cdc42 protein signal transduction |
GO:1902947 |
IEA:Ensembl | P | regulation of tau-protein kinase activity |
GO:0002021 |
IEA:Ensembl | P | response to dietary excess |
GO:0006979 |
IEA:Ensembl | P | response to oxidative stress |
GO:0043691 |
IEA:Ensembl | P | reverse cholesterol transport |
GO:0006641 |
IEA:Ensembl | P | triglyceride metabolic process |
GO:0042311 |
IEA:Ensembl | P | vasodilation |
GO:0034447 |
IEA:Ensembl | P | very-low-density lipoprotein particle clearance |